| In EUR m | Q1 2023 | Q1 2022 |
| Revenue | 409.9 | 385.0 |
| EBITDA (adjusted) | 97.2 | 94.6 |
| Exceptional items | -2.8 | -3.3 |
| EBITDA | 94.4 | 91.3 |
| Amortization, depreciation and impairment | -76.0 | -70.9 |
| thereof attributable to purchase price allocations and impairment losses | -4.9 | -6.9 |
| EBIT | 18.3 | 20.4 |
| Net finance income/costs | -13.6 | -6.0 |
| EBT | 4.7 | 14.4 |
| Taxes | -1.3 | -3.3 |
| Consolidated profit or loss for the period | 3.4 | 11.1 |
| Adjusted consolidated profit or loss for the period | 8.9 | 19.0 |
| Free cash flow (before M&A transactions) | 21.2 | -2.2 |
| Net debt (Mar. 31/Dec. 31) | 746.2 | 718.0 |
